openPR Logo
Press release

Non-Small Cell Lung Cancer Market to Witness Astonishing Growth by 2029

09-08-2023 10:57 AM CET | Health & Medicine

Press release from: Orion Market Research

Non-Small Cell Lung Cancer Market to Witness Astonishing Growth

The global non-small cell lung cancer market is anticipated to grow at a CAGR of 9.6% during the forecast period. The market growth is mainly attributed to the increase in air pollution across the globe. Rising pollution due to the number of carbon particles inhaled by humans causes several problems including lung cancer. The risk is sometimes equivalent to breathing second-hand tobacco smoke and comes from sources like industry, power generation, transportation, and domestic burning. Moreover, smoking cigarettes is also estimated to be one of the major causes of lung cancer among people. According to the reports of the American Cancer Society, In the US, 80% of lung cancer deaths are caused by smoking as the changes in the lung tissue begin almost immediately which damages the line of the lungs. Besides, the rising prevalence of cancer is driving the market growth. For instance, according to the International Agency for Research on Cancer, in 2020, there was around 227,875 lung cancer patient in theUS and it is estimated to reach at around 314,015 by 2040.

In addition to this, radiation, exposure to radon gas, certain metals, and some organic chemicals are some of the other factors that lead to lung cancer-causing the growth of the treatment of lung cancer. Government organizations and initiatives also play a major role in the treatment of lung cancer to increase the survival rate. For instance, in May 2020, FDA approved CYRAMZA in combination with erlotinib for the treatment of metastatic non-small cell lung cancer (NSCLC). Moreover, in the same month, FDA also improved Roche's Tecentriq for adults with metastatic non-small cell lung cancer (NSCLC) whose tumors have high PD-L1 expression. In addition to this, in January 2020, Bristol Myers Squibb received European Commission Approval for Opdivo (nivolumab) plus Yervoy (ipilimumab) with two cycles of chemotherapy for first-line treatment of metastatic Non-Small Cell Lung Cancer.

To Request a Sample of our Report on Non-Small Cell Lung Cancer Market: https://www.omrglobal.com/request-sample/non-small-cell-lung-cancer-market

Market Coverage

· The market number available for - 2022-2030

· Base year- 2022

· Forecast period- 2023-2030

Segment Covered-

· By Type

· By Therapy

· By Diagnosis

· By End-User

Regions Covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

Competitive Landscape- Eli Lilly and Co., Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co., Inc., AstraZeneca PLC, Novartis AG, and Bristol Myers Squibb Co., among others

Non-Small Cell Lung Cancer Market Segmentation

By Type

· Adenocarcinomas

· Squamous Cell Carcinoma

· Large Cell Carcinomas

· Others

By Therapy

· Chemotherapy

· Targeted Therapy

· Radiation Therapy

· Surgery

· Cryosurgery

· Others

By Diagnosis

· CT Scan

· X-Rays

· Sputum Cytology

· Bronchoscopy

· Laboratory Tests

· Thoracoscopy

· Others

By End-User

· Multispeciality Hospitals

· Cancer Research Centers

A full Report of Non-Small Cell Lung Cancer Market is Available @ https://www.omrglobal.com/industry-reports/non-small-cell-lung-cancer-market

Regional Analysis

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

Company Profiles

· AbbVie Inc.

· Agena Bioscience, Inc.

· Arqule Inc.

· Amgen Inc.

· AstraZeneca PLC

· Bayer AG

· Biodesix, Inc.

· Boehringer Ingelheim International GmbH

· Bristol Myers Squibb Co.

· DAIICHI SANKYO CO. LTD.

· Eli Lilly and Co.

· Exosome Diagnostics Corp.

· F. Hoffman-La Roche, Inc.

· Genentech, Inc.

· GlaxoSmithKline PLC

· Illumina, Inc.

· Merck & Co., Inc.

· Novartis International Ag

· Personal Genome Diagnostics Inc.

· Pfizer Inc.

· Qiagen NV

· Sanofi SA

· SAGA Diagnostics AB

· Thermo Fisher Scientific Inc.

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/non-small-cell-lung-cancer-market

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Non-Small Cell Lung Cancer Market to Witness Astonishing Growth by 2029 here

News-ID: 3201143 • Views:

More Releases from Orion Market Research

Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, …
Infrastructure as Code (IaC) Service Market was valued at approximately USD 0.932 billion, and it's projected to expand to around USD 7.509 billion by 2033, achieving a robust CAGR of 23.2% from 2024 to 2033. Infrastructure as Code (IaC) Service Market Overview The Infrastructure as Code (IaC) Service Market is experiencing remarkable expansion, fueled by the escalating need for scalable, automated infrastructure deployment across cloud and enterprise environments. In 2023, the market
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to Understanding the Process
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to …
Ultra High‐Performance Liquid Chromatography (UHPLC) Columns Market is estimated to be valued at USD 2.5 billion, and is projected to grow to approximately USD 4.8 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.8% from 2024 to 2033. Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market Overview The UHPLC columns market is on a strong growth trajectory, fueled by increasing demand for rapid, high-resolution analytical techniques across pharmaceuticals, biotechnology,
Property Management Service Market Rising Demand and Growth Forecast Through 2033
Property Management Service Market Rising Demand and Growth Forecast Through 203 …
Property Management Service Market was valued at approximately USD 17.3 billion. It is anticipated to reach around USD 32.0 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2033. Property Management Service Market Overview The Property Management Service Market is witnessing steady growth due to increasing urbanization, rising investments in real estate, and a growing demand for outsourced property management solutions. Property owners are increasingly
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSilicon Technologies Co., Ltd., ZTE Corporation,
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSili …
The global 5G chipset market was valued at USD 33.75 billion in 2024 and is projected to reach USD 502.66 billion by 2033, growing at a compound annual growth rate (CAGR) of 35% from 2025 to 2033. 5G Chipset Market Overview The 5G chipset market is experiencing rapid growth, driven by the global rollout of 5G networks and the increasing demand for high-speed, low-latency connectivity across various applications, including smartphones, IoT

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For